(Q44474850)

English

Atorvastatin markedly improves type III hyperlipoproteinemia in association with reduction of both exogenous and endogenous apolipoprotein B-containing lipoproteins

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Atorvastatin markedly improves type III hyperlipoproteinemia in association with reduction of both exogenous and endogenous apolipoprotein B-containing lipoproteins (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

7

object named as

Yuji Matsuzawa

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

Masato Ishigami

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Shizuya Yamashita

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Naohiko Sakai

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Ken-ichi Hirano

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Hisatoyo Hiraoka

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Tadashi Nakamura

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

168

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

359-366

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

The Biochemical, Clinical, and Genetic Features of Type III Hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Remnant lipoproteins induce endothelial plasminogen activator inhibitor-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Effect of statin therapy on remnant lipoprotein cholesterol levels in patients with combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Effects of atorvastatin on oxidized low-density lipoprotein, low-density lipoprotein subfraction distribution, and remnant lipoprotein in patients with mixed hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Establishment of monoclonal antibody against human Apo B-48 and measurement of Apo B-48 in serum by ELISA method.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

The effect of atorvastatin on serum lipids, lipoprotein(a) and plasma fibrinogen levels in primary dyslipidaemia--a pilot study involving serial sampling

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Lovastatin therapy in familial dysbetalipoproteinemia: effects on kinetics of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Effect of Pravastatin in the Treatment of Patients with Type III Hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Effect of atorvastatin treatment on lipoprotein lipase mass in the pre-heparin plasma in Japanese hyperlipidemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE*2 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Treatment with atorvastatin ameliorates hepatic very-low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: evidence that reduced hypertriglyceridemia is accompanied by improved hepat

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Reduction in hepatic non-esterified fatty acid concentration after long-term treatment with atorvastatin lowers hepatic triglyceride synthesis and its secretion in sucrose-fed rats

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Cholesterol esters regulate apoB48 secretion in CaCo2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Expression of type III hyperlipoproteinemia in apolipoprotein E2 (Arg158 --> Cys) homozygotes is associated with hyperinsulinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Changes of lipoprotein profile in familial dysbetalipoproteinemia with gemfibrozil

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900136-9

7 January 2021

Identifiers

10.1016/S0021-9150(03)00136-9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44474850&oldid=2025221126"